Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paula Tabares

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Pharmacognosy Research|January 7, 2012
Identification of the protease inhibitor miraziridine A in the Red sea sponge Theonella swinhoeiPaula Tabares, Björn Degel, Norbert Schaschke, et al.
General Hospital Psychiatry|July 10, 2013
Limbic encephalitis and psychosisKairav Shah, Nkiruka Iloh, Paula Tabares, et al.
Marine Biotechnology (New York, N.Y.)|January 12, 2011
Anti-protease and immunomodulatory activities of bacteria associated with Caribbean spongesPaula Tabares, Sheila M Pimentel-Elardo, Tanja Schirmeister, et al.
Clinical and Experimental Rheumatology|September 3, 2016
From TGN1412 to TAB08: the return of CD28 superagonist therapy to clinical development for the treatment of rheumatoid arthritisDmitry Tyrsin, Sergey Chuvpilo, Alexey Matskevich, et al.
American Journal of Human Genetics|June 28, 2003
BRD2 (RING3) is a probable major susceptibility gene for common juvenile myoclonic epilepsyDeb K Pal, Oleg V Evgrafov, Paula Tabares, et al.
European Journal of Immunology|October 13, 2017
Short-term cytokine stimulation reveals regulatory T cells with down-regulated Foxp3 expression in human peripheral bloodPaula Tabares, Susanne Berr, Daniela Langenhorst, et al.
Frontiers in Immunology|February 15, 2018
Self-Recognition Sensitizes Mouse and Human Regulatory T Cells to Low-Dose CD28 Superagonist StimulationDaniela Langenhorst, Paula Tabares, Tobias Gulde, et al.
European Journal of Immunology|December 31, 2013
Human regulatory T cells are selectively activated by low-dose application of the CD28 superagonist TGN1412/TAB08Paula Tabares, Susanne Berr, Paula S Römer, et al.
Phytochemistry|October 15, 2008
In vitro anti-influenza screening of several Euphorbiaceae species: structure of a bioactive Cyanoglucoside from Codiaeum variegatumJorge Eduardo Forero, Liliana Avila, Natalia Taborda, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 29, 2014
Cell contact-dependent priming and Fc interaction with CD32+ immune cells contribute to the TGN1412-triggered cytokine responsePatrick Bartholomaeus, Linda Y Semmler, Thomas Bukur, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Pharmacognosy Research|January 7, 2012
Identification of the protease inhibitor miraziridine A in the Red sea sponge Theonella swinhoeiPaula Tabares, Björn Degel, Norbert Schaschke, et al.
General Hospital Psychiatry|July 10, 2013
Limbic encephalitis and psychosisKairav Shah, Nkiruka Iloh, Paula Tabares, et al.
Marine Biotechnology (New York, N.Y.)|January 12, 2011
Anti-protease and immunomodulatory activities of bacteria associated with Caribbean spongesPaula Tabares, Sheila M Pimentel-Elardo, Tanja Schirmeister, et al.
Clinical and Experimental Rheumatology|September 3, 2016
From TGN1412 to TAB08: the return of CD28 superagonist therapy to clinical development for the treatment of rheumatoid arthritisDmitry Tyrsin, Sergey Chuvpilo, Alexey Matskevich, et al.
American Journal of Human Genetics|June 28, 2003
BRD2 (RING3) is a probable major susceptibility gene for common juvenile myoclonic epilepsyDeb K Pal, Oleg V Evgrafov, Paula Tabares, et al.
European Journal of Immunology|October 13, 2017
Short-term cytokine stimulation reveals regulatory T cells with down-regulated Foxp3 expression in human peripheral bloodPaula Tabares, Susanne Berr, Daniela Langenhorst, et al.
Frontiers in Immunology|February 15, 2018
Self-Recognition Sensitizes Mouse and Human Regulatory T Cells to Low-Dose CD28 Superagonist StimulationDaniela Langenhorst, Paula Tabares, Tobias Gulde, et al.
European Journal of Immunology|December 31, 2013
Human regulatory T cells are selectively activated by low-dose application of the CD28 superagonist TGN1412/TAB08Paula Tabares, Susanne Berr, Paula S Römer, et al.
Phytochemistry|October 15, 2008
In vitro anti-influenza screening of several Euphorbiaceae species: structure of a bioactive Cyanoglucoside from Codiaeum variegatumJorge Eduardo Forero, Liliana Avila, Natalia Taborda, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 29, 2014
Cell contact-dependent priming and Fc interaction with CD32+ immune cells contribute to the TGN1412-triggered cytokine responsePatrick Bartholomaeus, Linda Y Semmler, Thomas Bukur, et al.
Pageof 2